FDA approves first tissue adhesive for internal use

The FDA’s review of TissuGlu included data from a clinical study of 130 participants undergoing elective abdominoplasty

Novartis’ Cosentyx gets approval in Japan

Cosentyx approval is based on phase III programme demonstrating high, sustained efficacy in the skin clearance of moderate-to-severe plaque psoriasis

‘Our focus is on identifying other genes that contribute to hereditary cancers’

Dr T Rajkumar, Director and Scientific Director, Cancer Institute (WIA), Adyar elaborates about the ongoing research work at the institute as well as his perspective on what should be the priorities a

Psoriasis study demonstrates superiority of Novartis Cosentyx to Stelara in clearing skin

CLEAR is the second head-to-head study for Cosentyx following the phase III Fixture study that showed Cosentyx was superior to Enbrel (etanercept)

People with blood groups A, B and AB at higher risk of type II diabetes than group O

A 35 per cent increased risk of type II diabetes was found in those with group B

‘The government could do more in terms of how it sees research activities’

The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities, says this year’s winner of the Infosys Prize in the Life Sciences cat

Glenmark enrols first patient for phase II trial of GBR 500

The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011

US FDA votes against Novartis’ LBH589 compound

(ODAC) did not recommend the investigational compound LBH589, a pan-deacetylase inhibitor, for patients with previously treated multiple myeloma when used in combination with bortezomib [*] and dexame

Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients

The FDA Medicare analysis is based on patient data from elderly patients enrolled in Medicare

Psoriasis or rheumatoid arthritis linked to heart risk

Patients with psoriatic arthritis were 36 per cent more likely than the comparison group to suffer a heart attack

DRDO scientists develop Ayurveda-based drug for leucoderma

DIBER has transferred the technology of the drug, which is being showcased at the ongoing Arogya Expo 2014

Shantha’s investigational rotavirus vaccine enters phase III clinical trials in India

The live, oral, ready-to-use tetravalent rotavirus vaccine candidate is designed to protect young children from severe diarrhoea

Promethera Biosciences receives approval in Belgium

To enroll patients in the imminent HEP002 Phase IIb/ III clinical trial

US FDA approves first combination pill to treat hepatitis C

Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection

Akynzeo gets US FDA approval

Akynzeo treats nausea and vomiting in patients undergoing cancer chemotherapy

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market